No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared either component compound, or the blend formulation, as a drug for human or veterinary use
gene therapies gather interest Recently, TheracosBios Brenzavvy was approved by the agency as an oral medication for type 2 diabetes
COA Matrixyl Powder , as an important anti-aging cosmetic ingredient, has a wide range of applications in the field of skincare
Chen YW, Barson JR, Chen A, Hoebel BG, Leibowitz SF
Development, preclinical, and early clinical data on the GIP/GLP-1 receptor agonist tirzepatide Among the GIP/GLP-1 receptor agonists, tirzepatide (LY3298176) is the compound that is the most advanced in development and the first substance in this class that has received approval for the therapy of T2D by the FDA in May 2022 (manufacturer Eli Lilly Comp., trade name Mounjaro ) (5355)
ColonBroom's GLP-1 Premium formula is designed to support the body's natural metabolic processes without pharmaceutical ingredients